Biotechnology at Texas A&M University-Texarkana

Based on comparable biotechnology programs nationwide, Texas A&M-Texarkana's offering suggests earnings around $47,000 in the first year after graduation with roughly $20,400 in student debt. That debt-to-earnings ratio of 0.43 is manageable—you'd owe less than half of first-year salary—but the earnings figure itself deserves scrutiny. Similar programs in Texas, like the one at University of Houston, report first-year earnings closer to $50,000, suggesting Texarkana graduates might start slightly below the state average for this field.

The relatively modest starting salary becomes more concerning when you consider that biotechnology typically requires expensive lab equipment and specialized training. With 51% of students receiving Pell grants, many families here are counting on this degree to deliver strong financial returns. A $47,000 starting salary isn't catastrophic, but it's also not the kind of outcome that quickly justifies the investment, especially if students need additional credentials or relocate for better opportunities in biotech hubs.

Here's what matters for your decision: these estimates suggest this program tracks close to national norms but potentially trails other Texas options. If your student can access a biotech program at a larger research university in the state, the placement networks and industry connections might justify comparison shopping. For students committed to Texarkana specifically, ensure they're planning for geographic mobility after graduation—biotech opportunities cluster in major metros, not smaller border towns.